These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8139061)

  • 1. Tacrine for Alzheimer's disease. Which patient, what dose?
    Winker MA
    JAMA; 1994 Apr; 271(13):1023-4. PubMed ID: 8139061
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease.
    Hier DB
    Surg Neurol; 1997 Jan; 47(1):84-5. PubMed ID: 8986173
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic.
    Lyketsos CG; Corazzini K; Steele CD; Kraus MF
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):67-73. PubMed ID: 8845704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
    Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM
    N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrine in Alzheimer's disease.
    Cutler NR; Sramek JJ
    N Engl J Med; 1993 Mar; 328(11):808; author reply 809-10. PubMed ID: 8437603
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed-model analysis of incomplete longitudinal data from a high-dose trial of tacrine (Cognex) in Alzheimer's patients.
    Smith F
    J Biopharm Stat; 1996 Mar; 6(1):59-67. PubMed ID: 8838779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tacrine: progress in treatment of Alzheimer's disease?].
    Kurz A; Marquard R; Mösch D
    Z Gerontol Geriatr; 1995; 28(3):163-8. PubMed ID: 7664190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Should Alzheimer disease be treated with tacrine? Review of the literature].
    Arsland D; Laake K
    Tidsskr Nor Laegeforen; 1996 Sep; 116(23):2791-4. PubMed ID: 8928167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepidemiology of tacrine in Alzheimer's disease.
    Begaud B; Haramburu F; Miremont G
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tacrine in the treatment of Alzheimer's disease].
    Weinstein HC; Teunisse S; van Gool WA; van Crevel H
    Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1575-7. PubMed ID: 1922487
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy.
    Boller F; Orgogozo JM
    Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tacrine in Alzheimer's disease].
    López de Munain A
    Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's disease: the role of tacrine therapy.
    Jogerst G
    Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharma-clinics. Drug of the month. Tacrine (Cognex)].
    Scheen AJ
    Rev Med Liege; 1996 May; 51(5):379-81. PubMed ID: 8992561
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrine for Alzheimer's disease.
    Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia.
    Trzepacz PT; Ho V; Mallavarapu H
    Psychosomatics; 1996; 37(3):299-301. PubMed ID: 8849507
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrine and lecithin in Alzheimer's disease.
    BMJ; 1990 Apr; 300(6729):939-40. PubMed ID: 2337722
    [No Abstract]   [Full Text] [Related]  

  • 18. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease.
    Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977
    [No Abstract]   [Full Text] [Related]  

  • 19. Alzheimer's and Cognex.
    Steel JG
    N C Med J; 1995 Feb; 56(2):72-3. PubMed ID: 7741935
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacrine study shows benefits, high level of intolerance at high doses.
    Am J Hosp Pharm; 1994 Jul; 51(14):1762-3. PubMed ID: 7942902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.